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Abstract
Background: The Ca2+/calmodulin-stimulated adenylyl cyclase (AC) isoforms AC1 and AC8,
couple NMDA receptor activation to cAMP signaling pathways in neurons and are important for
development, learning and memory, drug addiction and persistent pain. AC1 and AC8 in the
anterior cingulate cortex (ACC) and the spinal cord were previously shown to be important in
subcutaneous inflammatory pain. Muscle pain is different from cutaneous pain in its characteristics
as well as conducting fibers. Therefore, we conducted the present work to test the role of AC1
and AC8 in both acute persistent and chronic muscle pain.
Results: Using an acute persistent inflammatory muscle pain model, we found that the behavioral
nociceptive responses of both the late phase of acute muscle pain and the chronic muscle
inflammatory pain were significantly reduced in AC1 knockout (KO) and AC1&8 double knockout
(DKO) mice. Activation of other adenylyl cyclases in these KO mice by microinjection of forskolin
into the ACC or spinal cord, but not into the peripheral tissue, rescued the behavioral nociceptive
responses. Additionally, intra-peritoneal injection of an AC1 inhibitor significantly reduced
behavioral responses in both acute persistent and chronic muscle pain.
Conclusion:  The results of the present study demonstrate that neuronal Ca2+/calmodulin-
stimulated adenylyl cyclases in the ACC and spinal cord are important for both late acute persistent
and chronic inflammatory muscle pain.
Background
In neurons, activity dependent cAMP synthesis is prima-
rily mediated by membrane bound Ca2+/calmodulin-
stimulated adenylyl cyclases (ACs). So far, ten members of
the adenylyl cyclase family have been identified [1]. Of
these, AC 1–9 isoforms are present in the brain (reviews,
[2,3]). Two of the adenylyl cyclases, AC1 and AC8, are
activated by calcium through the calcium-binding protein
calmodulin [3]. These enzymes link activity-dependent
increases in intracellular calcium to the production of
intracellular cAMP. In addition, these neuronal adenylyl
cyclases are viewed as coincidence detectors due to their
specific interaction with NMDA receptors and voltage-
dependent calcium channels at the neuronal membrane.
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The role of the cAMP pathway in neurons along the pain
pathway, including the anterior cingulate cortex (ACC)
and the spinal dorsal horn were demonstrated [4,5] and
discussed [6,7]. Peripheral injuries activate a series of sig-
naling molecules downstream of adenylyl cyclases in neu-
ronal populations. These molecules include pMAPK [8,9],
transcription factor pCREB [10-12], and the immediate
early genes Egr-1 [13,14] and Arc [15]. Neuronal adenylyl
cyclases were shown to contribute to NMDA receptor-
dependent synaptic potentiation in the hippocampus
[16,17]. Recently, we showed that Ca2+/calmodulin-stim-
ulated adenylyl cyclases are required to trigger synaptic
potentiation in the ACC neurons [18] and synaptic facili-
tation in the spinal cord dorsal horn [19].
Chronic myofascial pain represents a considerable health
problem [20]. Muscle pain is a symptom of various disor-
ders including fibromyalgia, metabolic myopathies,
myositis and also a side effect of medications, especially
the statin group of cholesterol lowering drugs [21,22].
Injury to the muscle results in diffuse aching pain that is
difficult to localize [23], spreading to regions outside the
area of innervation [24]. Inflammation induced by intra-
muscular injection of capsaicin or carrageenan results in
long-lasting (over weeks) bilateral secondary mechanical
hyperalgesia. On the other hand, injection of these agents
into the skin causes only a short-lasting, unilateral sec-
ondary mechanical hyperalgesia [25,26]. Although the
role of adenylyl cyclases was shown to be important in
behavioral sensitization associated with chronic subcuta-
neous inflammation and neuropathic pain [5,7,27], their
role in inflammatory muscle pain has not been studied.
In the present work, we adapted a chronic inflammatory
muscle pain model [28] and modified it to induce acute
muscle pain by intramuscular injection of formalin. To
overcome the non-selective action of adenylyl cyclase
inhibitors (e.g. SQ 22536) used in previous studies
[25,27], the present investigation used AC1  knockout
(KO), AC8 KO and AC1&8 double knockout (DKO) mice
to study the behavioral nociceptive changes after inducing
acute persistent pain (formalin injection) and chronic
pain (carrageenan injection) in comparison to the wild-
type mice.
Results
Effects of deletion of AC1 and AC8 on motor function
To test whether deletion of AC1, AC8 or AC1&8 has any
deleterious effect on muscle function, we tested their per-
formance on an accelerating RotaRod. This test is widely
used to assess motor ability in rodents by allowing them
to walk on a rotating drum. Our studies indicated that
AC1 and AC8 KO mice do not have any significant differ-
ence as compared to wild-type mice in their latency to fall
from the RotaRod (n = 5 mice in each group; p > 0.05; Fig.
1). To test the possibility of compensation of function in
these single KO mice, we performed the experiment on
AC1&8 DKO mice. Similar to single KO mice, there was
no significant difference between wild-type and DKO
mice, indicating that the absence of AC1, AC8 or a combi-
nation of both isoforms does not affect baseline motor
coordination.
Role of AC1 and AC8 on acute persistent inflammatory 
muscle pain
The contribution of AC1 and AC8 to the behavioral
responses to acute muscle pain induced by intramuscular
injection of 10 µL of 5% formalin (in normal saline) was
examined. The behavioral responses were measured
immediately after the injection. The formalin test is a
common test of tissue injury-mediated inflammatory
pain [5,29,30]. Licking and biting responses of the animal
on the injected leg were observed for 120 min (wild-type
n = 4 mice; AC1 KO, n = 8 mice, AC8 KO, n = 8 mice, p <
0.05) (Fig. 2A, 2C). Formalin-induced behavioral
responses consisted of three phases [5]. The first phase
consisted of the first 10 min after the injection in which
behavioral responses were not significantly altered in AC1
KO or AC8 KO mice (Fig. 2B, 2D), indicating that AC1
and AC8 do not significantly contribute to the early phase
of acute sensory responses to formalin independently.
However, AC1&8 DKO mice showed significant reduction
in the first phase. A significant difference was observed
between wild-type and AC1 KO mice in phase 2, (n = 8
mice, p < 0.05) indicating the specific role of this Ca2+/cal-
modulin-stimulated adenylyl cyclase during the interme-
diate stage of nociception. In the final stage, behavioral
responses of AC1  KO mice were significantly reduced
Test of motor function in wild-type and AC KO mice Figure 1
Test of motor function in wild-type and AC KO mice. 
Graph showing the latent period to fall from the accelerating 
RotaRod. There was no significant difference between wild-
type, AC1 KO, AC8 KO, and AC1&8 DKO mice for the 
latency to fall, demonstrating that the motor function is 
intact. n = 5 mice in each group; p > 0.05.Molecular Pain 2006, 2:7 http://www.molecularpain.com/content/2/1/7
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compared to wild-type mice. By contrast, AC8 KO mice
did not show significant behavioral changes in any of the
phases compared to wild-type mice. In AC1&8 DKO mice,
we found significantly reduced responses to formalin in
phase three of behavioral responses (n = 8 mice, p < 0.05;
Fig. 3A). These differences in responses in the different
phases among AC1 KO, AC8 KO and AC1&8 DKO mice
are possibly due to different molecular requirements
Behavioral nociceptive responses to intramuscular formalin in AC1 and AC8 single KO mice Figure 2
Behavioral nociceptive responses to intramuscular formalin in AC1 and AC8 single KO mice. Cumulative response 
for each 5 minutes time is plotted on y axis as duration of responses. A. Comparison of nociceptive responses to intramuscular 
formalin in wild-type and AC1 KO mice. Wild-type, n = 4 mice; AC1 KO, n = 8 mice. B. Data from experiment A is grouped as 
early, intermediate and late phases in comparison with wild-type mice. p < 0.05. *Significant difference from wild-type mice. C. 
Comparison of nociceptive responses to intramuscular formalin in wild-type and AC8 KO mice. Wild-type, n = 4 mice; AC8 
KO, n = 8 mice. D. Data from experiment C is grouped as early, intermediate and late phases in comparison with wild-type 
mice.Molecular Pain 2006, 2:7 http://www.molecularpain.com/content/2/1/7
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involved in different stages of acute persistent inflamma-
tory muscle pain.
Chronic inflammatory muscle pain
To test the role of adenylyl cyclases in chronic inflamma-
tory pain, we used AC1&8  DKO mice. The pain was
induced by injecting 20 µL of carrageenan into the left gas-
trocnemius muscle, a protocol that was modified based
on similar studies in the rat [26]. Injections were given on
day 1 and day 5. Hind paw withdrawal to non-noxious
mechanical pressure by a 2.44 mN von Frey fiber was
measured before and at different time points after injec-
tion (wild-type, n = 5 mice, AC1&8 DKO, n = 8 mice) (Fig.
4A). The withdrawal response to mechanical force was
increased 4 hours after the first carrageenan intramuscular
injection. During the early phase and up to day 5, behav-
ioral responses were not statistically different between
wild-type and AC1&8 DKO mice (p > 0.05; Fig. 4B). On
the following days, there was a gradual decrease in
mechanical allodynia in AC1&8  DKO. These KO mice
showed a statistically significant reduction in mechanical
allodynia on the ipsilateral side by day 9 (p < 0.05; Fig.
4C). This significant reduction in mechanical allodynia
was observed bilaterally on day 12 and remained reduced
until the end of the experiment on day 28. This indicates
that AC1 and 8 are involved in maintaining long lasting
allodynia and in activating signal transduction pathways
that lead to long lasting chronic muscle pain.
Inhibition of nociceptive responses in acute and chronic 
inflammatory muscle pain by the novel AC1 inhibitor
AC1 is more sensitive to calcium than AC8 [3]. Therefore,
we decided to study the effect of blocking AC1 in both
acute and chronic muscle pain. A novel AC1 inhibitor
NB001 produced a significant reduction in behavioral
responses to acute muscle inflammatory pain at doses
ranging from 0.1 to 5 mg/kg body weight with a peak
response at 1 mg/kg body weight (n = 6 mice; p < 0.001;
Fig. 5A). The initial phase of the licking response during
the first ten minutes was not changed after blockade of
AC1 with NB001, similar to that observed in AC1 KO
mice and as reported previously [5]. The total responses
were reduced to almost one fourth, indicating that the
AC1 inhibitor, at a concentration of 1 mg/kg body weight,
is sufficient to block AC1 activity. The effect of the same
AC1 inhibitor was also tested on chronic inflammatory
muscle pain. NB001 significantly reduced mechanical
allodynia at doses ranging from 0.1 to 1 mg/kg (n = 4
mice; p < 0.05; Fig. 5B); 1 mg/kg maximally reduced the
mechanical allodynia, similar to that in acute inflamma-
tory pain responses.
Activation of non-Ca2+/calmodulin-stimulated adenylyl 
cyclases in the ACC 'rescued' behavioral sensitization
To examine whether activation of other adenylyl cyclases
rescues the mechanical allodynia phenotype seen in the
carrageenan muscle pain model in AC1&8 DKO mice, we
injected forskolin (a non-specific adenylyl cyclase activa-
tor) into either the ACC, spinal cord or muscle on day 9
when mechanical allodynia was significantly reduced. The
dose of forskolin was determined based on similar injec-
tions into the hippocampus and ACC in previous studies
[5]. We performed microinjection of forskolin (12 nmolar
solution, 0.5 µl) into both sides of the ACC of AC1&8
DKO mice (forskolin injection, n = 6 mice; vehicle injec-
tion, n = 4 mice; Fig. 6A, B). Mechanical allodynia was
measured 1 hour after forskolin injection. Microinjection
of forskolin bilaterally into the ACC produced mechanical
allodynia ipsilaterally one hour after injection and
remained elevated for 24 hours (Fig. 6C) (forskolin injec-
tion, n = 6 mice; vehicle injection, n = 4 mice; p < 0.05).
The data suggests that cAMP produced by forskolin
through the activation of other adenylyl cyclases in
AC1&8 DKO can rescue mechanical allodynia. This find-
ing, thus excludes the possibility that behavioral defects in
DKO are due to developmental changes.
Activation of adenylyl cyclases in the spinal cord, but not 
in peripheral tissue, rescued mechanical allodynia
In addition to the ACC, the dorsal horn of the spinal cord
is also important in regulating the threshold for mechan-
ical allodynia. Intrathecal injection of forskolin in AC1&8
DKO mice produced mechanical allodynia bilaterally
(Fig. 7A) (forskolin injection, n = 4 mice; vehicle injec-
tion, n = 3 mice; p < 0.05). This indicated that activation
of adenylyl cyclases in the spinal cord by forskolin pro-
duced sufficient cAMP to activate the downstream cas-
cade, rescuing the mechanical allodynia. To test whether
there is similar activation of adenylyl cyclases at the
peripheral nerve endings in the muscle, we injected for-
skolin into the gastrocnemius muscle, where muscle injec-
tions were originally given. This did not produce any
significant effect on mechanical allodynia (Fig. 7B) (for-
skolin injection, n = 4 mice; vehicle injection,n = 3 mice;
p > 0.05) indicating that peripheral activation of adenylyl
cyclases, either within the nerve endings or in the non-
neuronal cells, to increase cAMP has no effect in reducing
the threshold of mechanical allodynia.
Discussion
The present study examined the role of Ca2+/calmodulin-
stimulated adenylyl cyclases AC1 and AC8 in both acute
persistent and chronic muscle pain. AC1 and AC8 act
downstream from NMDA receptors and contribute to
NMDA receptor-dependent synaptic potentiation lasting
several hours [16]. Our results provide genetic, pharmaco-
logical and behavioral evidence that adenylyl cyclase iso-Molecular Pain 2006, 2:7 http://www.molecularpain.com/content/2/1/7
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forms AC1 and AC8 are important for behavioral
sensitization after muscle inflammation. Previous studies
have examined the role of AC1 and AC8 in behavioral
allodynia in subcutaneous inflammation [5]. Since the
characteristics of pain arising from the muscle inflamma-
Behavioral responses to intramuscular formalin in AC1&8  DKO in comparison with wild-type mice Figure 3
Behavioral responses to intramuscular formalin in 
AC1&8 DKO in comparison with wild-type mice. 
Cumulative response for each 5 min time is plotted on y axis 
as duration of responses. A. Comparison of nociceptive 
responses to intramuscular formalin in wild-type and AC1&8 
DKO mice. Wild-type, n = 4 mice; AC1&8DKO, n = 8 mice; 
B. Data from experiment A is grouped as early, intermediate 
and late phases in comparison with wild-type mice. p < 0.05. 
*Significant difference from wild-type mice.
Mechanical allodynia in chronic inflammatory muscle pain Figure 4
Mechanical allodynia in chronic inflammatory muscle 
pain. Intramuscular injections of carrageenan were given on 
day 1 and 5. The data is plotted as percentage of responses 
out of 10 mechanical stimuli over the dorsum of the foot at 
an interval of 5 min. Wild-type, n = 5 mice; AC1&8 DKO, n = 
8 mice. A. The behavioral responses of animals to a non-nox-
ious mechanical stimulus were recorded on the ipsilateral 
side. 5b denotes time point before second injection of carra-
geenan on day 5; 5a denotes time point after second injection 
of carrageenan on day 5. B. Mechanical allodynia on day 5 fol-
lowing the second intramuscular injection of carrageenan. 
There was no statistical difference between the wild-type and 
DKO mice on both ipsilateral and contralateral sides. C. 
Mechanical allodynia on day 9. Significant differences in 
mechanical allodynia were present between the wild-type 
and DKO mice on both ipsilateral and contralateral sides. p < 
0.05. *Significant difference from wild-type mice.Molecular Pain 2006, 2:7 http://www.molecularpain.com/content/2/1/7
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tion is different from that of cutaneous pain [23,24], we
investigated the role of Ca2+/calmodulin-stimulated ade-
nylyl cyclases in both acute persistent and chronic muscle
inflammation. The behavioral responses during the early
phase, after intramuscular formalin injection, were not
significantly reduced either in AC1 or in AC8 single KO
mice compared to the wild-type (Fig. 2B &2D). The
behavioral responses during the late phase were signifi-
cantly reduced in AC1 KO as well as AC1&8 DKO indicat-
ing that AC1 has direct contribution towards the late
phase of acute persistent muscle pain.
Adenylyl cyclases and synaptic enhancement
Ca2+/calmodulin-stimulated ACs are activated by NMDA
receptor-mediated calcium entry and the reduction in the
late phase of the formalin lick test may be due to the loss
of NMDA receptor-dependent synaptic potentiation that
normally lasts for several hours [16]. Our recent study has
demonstrated that Ca2+/calmodulin-stimulated adenylyl
cyclases are required for triggering NMDA receptor
dependent synaptic potentiation in ACC neurons [18].
Therefore, one possibility is that the absence of Ca2+/cal-
modulin-stimulated adenylyl cyclases in KO mice pre-
vents NMDA-dependent synaptic potentiation and leads
to reduction in behavioral responses in the late phase of
the formalin lick test. The activation of intra and/or extra-
neuronal adenylyl cyclases in the ACC rescued mechanical
allodynia. While the reason for this is not yet known, we
hypothesize that direct activation of non-Ca2+/calmodu-
lin-stimulated adenylyl cyclases may initiate cellular
changes in neuronal and/or non-neuronal cells ultimately
triggering downstream pathways following the cAMP step
in neurons. In the spinal cord, the role of Ca2+/calmodu-
lin-stimulated adenylyl cyclases is different. cAMP gener-
ated by adenylyl cyclase stimulated by forskolin acts
synergistically with 5 HT to recruit functional AMPA
receptors and provides a mechanism for long-lasting syn-
aptic enhancement [19]. Therefore, activation of adenylyl
cyclases by forskolin at the spinal cord is also a contribu-
tory mechanism for the phenotypic rescue in AC1&8 DKO
mice after intrathecal injection.
Role of adenylyl cyclases in maintaining chronicity of 
mechanical allodynia
Chronic inflammation caused by carrageenan induced a
sensitization process (allodynia) in normal animals.
Repeated injections of carrageenan on days 1 and 5 were
sufficient to maintain this allodynia up to day 28. In DKO
mice, nociceptive responses were reduced by day 9. While
adenylyl cyclases are required for maintaining the late
phases, it cannot be ruled out that initiation of the activity
by these Ca2+/calmodulin-stimulated adenylyl cyclases in
the early phase is required for activation of downstream
cascades that maintains the late phases. The cAMP synthe-
sis induced by nociceptive responses during persistent
pain may have a dose-dependent effect on a downstream
cascade that regulates adenylyl cyclase synthesis and activ-
ity. In addition, coupling of calcium and cAMP systems
may result in an ordered activation or a positive feedback
regulation of calcium and cAMP dependent protein
kinases and possibly provide positive feedback regulation
of calcium channels, thus maintaining mechanical allody-
nia. Elevated cAMP signals arising from activation of AC1
and 8 by calcium may therefore play an important role in
synaptic plasticity associated with chronic muscle pain.
Effect of novel AC1 inhibitor in acute persistent and chronic  muscle inflammation Figure 5
Effect of novel AC1 inhibitor in acute persistent and 
chronic muscle inflammation. A. Novel AC1 inhibitor 
NB001 produced significant reduction of licking responses in 
the late phase of the formalin test with peak response at 1 
mg/kg body weight. n = 6 mice;p < 0.05. *Significant differ-
ence from vehicle. B. Effect of AC1 inhibitor NB001 on 
mechanical allodynia after chronic muscle inflammation. n = 4 
mice; p < 0.05. *Significant difference from vehicle.Molecular Pain 2006, 2:7 http://www.molecularpain.com/content/2/1/7
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The present study demonstrates that Ca2+/calmodulin-
stimulated adenylyl cyclases AC1 and 8 induce a sensi-
tized state in the nociceptive pathway and provides evi-
dence that they are critical in the maintenance of muscle
inflammatory pain. Specifically, the role of highly calcium
sensitive AC1 is critical as evidenced by the significant
reduction of behavioral nociceptive responses in the late
phase of both acute and chronic muscle pain following
intra-peritoneal injection of the AC1 inhibitor. However,
in animals with genetic deletion of AC1 and AC8, forsko-
lin may rescue behavioral phenotypes by activating non-
Ca2+/calmodulin-stimulated adenylyl cyclases in both the
ACC and spinal cord. These results indicate that cAMP sig-
naling in both the ACC and spinal cord are important for
the maintenance of chronic muscle inflammatory pain.
Taken together, the results of our previous report [5] and
the present study consistently suggest that Ca2+/calmodu-
lin-stimulated neuronal adenylyl cyclases play a key role
in mediating the late phase of acute persistent as well as
chronic inflammatory pain.
Methods
Animals
Adult (8–12 weeks) male mice lacking adenylyl cyclase
isoforms AC1, AC8 and both AC1 and AC8 [5,16,31] were
maintained on a C57BL/6 background and were crossed
back at least 12 generations. Adult (8–12 weeks) C57BL/6
mice were used as controls. KO mice were well groomed
and did not show any signs of congenital abnormalities or
motor coordination defects. Experimenters were blind to
the genotype. Animals were maintained on a 12 hour light
dark cycle with food and water available ad libitum. The
experimental protocols were approved by the Animal
Care Committee at the University of Toronto.
Motor function test
Motor function was tested using an accelerating RotaRod
(Med Associates). One hour before testing, animals were
trained on the RotaRod at a constant acceleration of 16
rpm until they could remain on for a 30-sec period. The
RotaRod test was performed by measuring the time each
animal was able to maintain its balance walking on the
rotating drum. The RotaRod accelerated from 4 to 40 rpm
over a 5-min period. Mice were given three trials with a
maximum time of 300 sec and a 5 min inter-trial rest
interval. The latency to fall was taken as a measure of
motor function. Some mice hold on to the rotating drum
instead of walking. For these mice, the latency to fall was
recorded after 2 complete rotations.
Formalin lick test for acute inflammatory muscle pain
Formalin (10 µL; 5% in normal saline) was injected deep
into the gastrocnemius muscle on the left side. The needle
was directed from the lateral side to avoid any bone pen-
etration and the tip was stopped at the middle of the mus-
Rescue of mechanical allodynia by bilateral injection of for- skolin into the ACC Figure 6
Rescue of mechanical allodynia by bilateral injection 
of forskolin into the ACC. A. Site of bilateral injection of 
forskolin into the ACC in coronal plane. Injections were 
made at 0.7 mm anterior to the bregma, 0.3 mm lateral to 
the midline and 1.75 mm ventral to the skull. B. Bilateral 
ACC microinjection sites of vehicle (in green) and forskolin 
(in red). The coronal section is 0.7 mm anterior to the 
bregma. C. Forskolin rescued behavioral allodynia in carra-
geenan induced chronic muscle pain in AC1&8 DKO mice on 
day 9 on the ipsilateral side. Forskolin injection, n = 6 mice; 
Vehicle injection, n = 5 mice. p < 0.05. *Significant difference 
from vehicle injection.Molecular Pain 2006, 2:7 http://www.molecularpain.com/content/2/1/7
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cle for injection. The total time spent licking or biting the
injected left leg, including the thigh and paw, was
recorded every 5 min for 2 hours immediately following
the injection. Responses from 0 to 10 min were plotted as
early nociceptive responses, those from 10 to 55 min as
intermediate, and those from 55 to 120 min as late nocic-
eptive responses.
Chronic inflammatory muscle pain model
Mice were briefly anaesthetized with isoflurane. 20 µL of
carrageenan (3%, in normal saline pH 7.2, 20 µL) or nor-
mal saline control (pH 7.2) was injected into the left gas-
trocnemius muscle, as described in the formalin lick test.
This protocol was adapted from similar experiments that
induced chronic muscle pain in rats [26]. Care was taken
during the injections due to the high viscosity of carra-
geenan. The injection site was mildly massaged to ensure
proper diffusion of the drug from the injection site. To
induce chronic muscle pain, two intramuscular injections
of carrageenan were administered on days 1 and 5.
Measurement of mechanical allodynia
Mice were allowed to acclimatize to the chamber for 30
min before testing. A threshold stimulus was determined
by an animal's paw withdrawal upon application of a von
Frey filament (Stoelting, Wood Dale, Illinois) over the
dorsum of the left hind paw to the point of bending.
Mechanical sensitivity of the animal to the innocuous
pressure of a 0.4 mN von Frey filament (No.2.44) was
scored and repeated every 5 min for up to 10 times. Posi-
tive responses included prolonged hind paw withdrawal
followed by licking or scratching and these responses were
plotted as percentage positive responses. Injections were
carried out on days 1 and 5. Mechanical allodynia was
tested on days 1, 2, 5 (before and after injection), 6, 8, 9,
12 and 28. For rescue experiments with forskolin,
mechanical allodynia was tested thirty minutes after for-
skolin microinjection. A two-way analysis of variance
(ANOVA) was used to compare differences.
Intraperitoneal injection of AC1 inhibitor
The novel AC1 inhibitor NB001 was dissolved in 1%
DMSO in normal saline and injected into the peritoneal
cavity in doses varying from 0.1 to 5 mg/kg body weight
in a volume of 10 µL/gram body weight. The effect of the
drug was tested 30 minutes after the injection.
ACC injections
After anesthetizing with 2% halothane (30% O2 balanced
with nitrogen), mice were placed in a Kopf stereotaxic
instrument. A microinjection apparatus, consisting of a
Hamilton syringe (50 µL) connected to an injector needle
(30 gauge) by a thin polyethylene tube and a motorized
syringe pump (Razel Scientific Instruments Inc., Stam-
ford, Connecticut), was used to perfuse the drugs. The
skin over the scalp was incised at the midline and bilateral
openings were made in the skull to allow the insertion of
a microinjection needle into the ACC. The coordinates of
the injection were as follows: 0.7 mm anterior to Bregma,
0.3 mm lateral to the midline, and 1.75 mm ventral to the
Effect of spinal intrathecal and intramuscular forskolin on  behavioral allodynia in chronic inflammatory muscle pain in  AC1&8 DKO mice Figure 7
Effect of spinal intrathecal and intramuscular forsko-
lin on behavioral allodynia in chronic inflammatory 
muscle pain in AC1&8 DKO mice. A. Intrathecal injec-
tion of forskolin rescued mechanical allodynia. Forskolin 
injection, n = 4 mice; Vehicle injection, n = 3 mice. p < 0.05. 
*Significant difference from vehicle injection. B. Intramuscular 
injection of forskolin did not rescue mechanical allodynia. 
Forskolin injection, n = 4 mice; Vehicle injection, n = 3 mice. 
p > 0.05Molecular Pain 2006, 2:7 http://www.molecularpain.com/content/2/1/7
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surface of the skull [32]. Either 0.5 µl forskolin (12 nmo-
lar) or a vehicle solution (20% DMSO in filter-sterilized
phosphate-buffered saline, pH 7.4) was infused at a rate
of 0.05 µl/min. The needle was withdrawn 5 min after
completion of the injection. Upon completion of experi-
ments, all animals were deeply anesthetized and perfused
transcardially with saline, followed by 4% paraformalde-
hyde. Serial cryostat coronal sections (30 µm) of the ACC
were mounted on glass slides, counterstained with hema-
toxylin and examined under the microscope to confirm
the site of injection. All chemicals were purchased from
Sigma (St. Louis, MO).
Spinal intrathecal injections
After anesthetizing with 2% halothane with 30% O2 bal-
anced with nitrogen, mice were placed in a Kopf stereo-
taxic instrument. The anesthesia set-up was the same as
that used for the ACC microinjection. The lumbar verte-
brae were slightly flexed, spines were palpated and the
needle was advanced manually through the inter-spinal
space lateral to the spinous processes as described [33].
Either 0.5 µl forskolin (12 nmolar) or a vehicle solution
(20% DMSO in filter-sterilized phosphate-buffered
saline, pH 7.4) was infused at a rate of 0.05 µl/min. After
the completion of the injection, the needle was kept in
place for 5 min before the withdrawal.
Data Analysis
Results are expressed as mean ± standard error of the
mean (SEM). Statistical comparisons were performed by a
two-way ANOVA. p < 0.05 was considered statistically sig-
nificant. For the RotaRod test, data were analyzed using a
one-way ANOVA.
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